Benchmark on Drug Target Interaction Modeling from a Structure Perspective
0
Sign in to get full access
Overview
- Provides a benchmark for evaluating drug-target interaction (DTI) modeling approaches from a structural perspective
- Focuses on predicting whether a drug molecule will bind to a target protein based on their 3D structures
- Includes a comprehensive dataset and set of evaluation metrics to assess the performance of DTI models
Plain English Explanation
The paper presents a benchmark for evaluating how well machine learning models can predict if a drug molecule will bind to a target protein based on their 3D structures. This is an important problem in drug discovery, as identifying potential drug-target interactions can help researchers develop new medications.
The researchers created a dataset of known drug-target interactions and used it to assess the performance of different DTI modeling approaches. They looked at factors like how accurately the models could predict binding, how efficiently they could make those predictions, and how well they could generalize to new data.
By providing a standardized benchmark, the paper aims to help researchers compare the strengths and weaknesses of various DTI modeling techniques. This can guide the development of more effective and reliable methods for predicting drug-target interactions from 3D structural data.
Technical Explanation
The paper introduces a new benchmark for drug-target interaction (DTI) modeling from a structural perspective. The goal is to predict whether a given drug molecule will bind to a target protein based on their 3D structures.
The researchers curated a comprehensive dataset of drug-target interactions, including 3D structures for the drug molecules and target proteins. They defined several evaluation metrics to assess DTI model performance, including binding affinity prediction accuracy, binding site prediction accuracy, and computational efficiency.
The paper then reviews different DTI modeling approaches, including docking-based methods, machine learning models that use chemical and structural features, and deep learning architectures that learn directly from 3D structural data. The authors evaluate these methods on the benchmark dataset and compare their strengths and weaknesses.
Critical Analysis
The benchmark presented in this paper is a valuable contribution to the field of structure-based drug design. By providing a standardized dataset and evaluation protocol, it allows researchers to more rigorously compare different DTI modeling techniques.
However, the authors acknowledge some limitations of their work. The dataset, while comprehensive, may not fully capture the diversity of real-world drug-target interactions. Additionally, the 3D structural data used in the benchmark may not always be available or accurate for real-world drug discovery applications.
Further research is needed to explore how well these DTI modeling approaches generalize to more diverse datasets and real-world drug discovery scenarios. Incorporating additional data sources, such as molecular dynamics or experimental binding kinetics, could also help improve the predictive power and practical relevance of these models.
Conclusion
This paper presents a valuable benchmark for evaluating drug-target interaction modeling approaches from a structural perspective. By providing a standardized dataset and evaluation framework, it aims to help researchers develop more effective and reliable methods for predicting drug-target binding based on 3D structural data.
The benchmark highlights the strengths and limitations of various DTI modeling techniques, guiding future research and development in this important area of drug discovery. Continued work to expand the scope and realism of the benchmark can further advance the state of the art in structure-based drug design.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
Benchmark on Drug Target Interaction Modeling from a Structure Perspective
Xinnan Zhang, Jialin Wu, Junyi Xie, Tianlong Chen, Kaixiong Zhou
The prediction modeling of drug-target interactions is crucial to drug discovery and design, which has seen rapid advancements owing to deep learning technologies. Recently developed methods, such as those based on graph neural networks (GNNs) and Transformers, demonstrate exceptional performance across various datasets by effectively extracting structural information. However, the benchmarking of these novel methods often varies significantly in terms of hyperparameter settings and datasets, which limits algorithmic progress. In view of these, we conduct a comprehensive survey and benchmark for drug-target interaction modeling from a structure perspective, via integrating tens of explicit (i.e., GNN-based) and implicit (i.e., Transformer-based) structure learning algorithms. To this end, we first unify the hyperparameter setting within each class of structure learning methods. Moreover, we conduct a macroscopical comparison between these two classes of encoding strategies as well as the different featurization techniques that inform molecules' chemical and physical properties. We then carry out the microscopical comparison between all the integrated models across the six datasets, via comprehensively benchmarking their effectiveness and efficiency. Remarkably, the summarized insights from the benchmark studies lead to the design of model combos. We demonstrate that our combos can achieve new state-of-the-art performance on various datasets associated with cost-effective memory and computation. Our code is available at hyperlink{https://github.com/justinwjl/GTB-DTI/tree/main}{https://github.com/justinwjl/GTB-DTI/tree/main}.
Read more7/8/2024
🔮
0
HiGraphDTI: Hierarchical Graph Representation Learning for Drug-Target Interaction Prediction
Bin Liu, Siqi Wu, Jin Wang, Xin Deng, Ao Zhou
The discovery of drug-target interactions (DTIs) plays a crucial role in pharmaceutical development. The deep learning model achieves more accurate results in DTI prediction due to its ability to extract robust and expressive features from drug and target chemical structures. However, existing deep learning methods typically generate drug features via aggregating molecular atom representations, ignoring the chemical properties carried by motifs, i.e., substructures of the molecular graph. The atom-drug double-level molecular representation learning can not fully exploit structure information and fails to interpret the DTI mechanism from the motif perspective. In addition, sequential model-based target feature extraction either fuses limited contextual information or requires expensive computational resources. To tackle the above issues, we propose a hierarchical graph representation learning-based DTI prediction method (HiGraphDTI). Specifically, HiGraphDTI learns hierarchical drug representations from triple-level molecular graphs to thoroughly exploit chemical information embedded in atoms, motifs, and molecules. Then, an attentional feature fusion module incorporates information from different receptive fields to extract expressive target features.Last, the hierarchical attention mechanism identifies crucial molecular segments, which offers complementary views for interpreting interaction mechanisms. The experiment results not only demonstrate the superiority of HiGraphDTI to the state-of-the-art methods, but also confirm the practical ability of our model in interaction interpretation and new DTI discovery.
Read more4/17/2024
🌐
0
MKDTI: Predicting drug-target interactions via multiple kernel fusion on graph attention network
Yuhuan Zhou, Yulin Wu, Weiwei Yuan, Xuan Wang, Junyi Li
Drug-target relationships may now be predicted computationally using bioinformatics data, which is a valuable tool for understanding pharmacological effects, enhancing drug development efficiency, and advancing related research. A number of structure-based, ligand-based and network-based approaches have now emerged. Furthermore, the integration of graph attention networks with intricate drug target studies is an application area of growing interest. In our work, we formulate a model called MKDTI by extracting kernel information from various layer embeddings of a graph attention network. This combination improves the prediction ability with respect to novel drug-target relationships. We first build a drug-target heterogeneous network using heterogeneous data of drugs and targets, and then use a self-enhanced multi-head graph attention network to extract potential features in each layer. Next, we utilize embeddings of each layer to computationally extract kernel matrices and fuse multiple kernel matrices. Finally, we use a Dual Laplacian Regularized Least Squares framework to forecast novel drug-target entity connections. This prediction can be facilitated by integrating the kernel matrix associated with the drug-target. We measured our model's efficacy using AUPR and AUC. Compared to the benchmark algorithms, our model outperforms them in the prediction outcomes. In addition, we conducted an experiment on kernel selection. The results show that the multi-kernel fusion approach combined with the kernel matrix generated by the graph attention network provides complementary insights into the model. The fusion of this information helps to enhance the accuracy of the predictions.
Read more7/16/2024
🔮
0
A Cross-Field Fusion Strategy for Drug-Target Interaction Prediction
Hongzhi Zhang, Xiuwen Gong, Shirui Pan, Jia Wu, Bo Du, Wenbin Hu
Drug-target interaction (DTI) prediction is a critical component of the drug discovery process. In the drug development engineering field, predicting novel drug-target interactions is extremely crucial.However, although existing methods have achieved high accuracy levels in predicting known drugs and drug targets, they fail to utilize global protein information during DTI prediction. This leads to an inability to effectively predict interaction the interactions between novel drugs and their targets. As a result, the cross-field information fusion strategy is employed to acquire local and global protein information. Thus, we propose the siamese drug-target interaction SiamDTI prediction method, which utilizes a double channel network structure for cross-field supervised learning.Experimental results on three benchmark datasets demonstrate that SiamDTI achieves higher accuracy levels than other state-of-the-art (SOTA) methods on novel drugs and targets.Additionally, SiamDTI's performance with known drugs and targets is comparable to that of SOTA approachs. The code is available at https://anonymous.4open.science/r/DDDTI-434D.
Read more5/24/2024